Treatment of schizophrenia with long-acting injectable risperidone : a 12-month open-label trial of the first long-acting second-generation antipsychotic.

Nyckelord

Administration; Oral

Adolescent

Adult

Adverse Drug Reaction Reporting Systems

Aged

Aged; 80 and over

Antipsychotic Agents/*administration & dosage/adverse effects

Comparative Study

Delayed-Action Preparations

Dose-Response Relationship; Drug

Drug Administration Schedule

Drug Therapy; Combination

Dyskinesia; Drug-Induced/diagnosis/etiology

Female

Humans

Injections; Intramuscular

Male

Middle Aged

Neurologic Examination/drug effects

Psychiatric Status Rating Scales

Research Support; Non-U.S. Gov't

Risperidone/*administration & dosage/adverse effects

Schizophrenia/diagnosis/*drug therapy

Schizophrenic Psychology

Treatment Outcome

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)